lithium hexafluorostannate(iv) structure
|
Common Name | lithium hexafluorostannate(iv) | ||
---|---|---|---|---|
CAS Number | 17029-16-2 | Molecular Weight | 246.57300 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | F6Li2Sn | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | lithium hexafluorostannate(iv) |
---|---|
Synonym | More Synonyms |
Molecular Formula | F6Li2Sn |
---|---|
Molecular Weight | 246.57300 |
Exact Mass | 247.92500 |
LogP | 2.14040 |
Appearance of Characters | Powder | white |
Water Solubility | Insoluble in water. |
Section 1: Product Identification Chemical Name:Lithium hexafluorostannate (IV), 99% CAS Registry Number:17029-16-2 Formula:Li2SnF6 EINECS Number:none Chemical Family:halometallate salts Synonym:Dilithium tin hexafluoride
Section 2: Composition and Information on Ingredients IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL) Title Compound17029-16-2100%2mg/m3 (as Sn)2mg/m3 (as Sn) Section 3: Hazards Identification Irritating to eyes and skin. Large doses of soluble lithium salts are toxic to the central nervous system and on Emergency Overview: repeated ingestion may damage kidneys and act as a teratogen Primary Routes of Exposure:Ingestion, Inhalation, skin, eyes Eye Contact:Causes irritation and serious eye damage. Effects may not immediately appear. Causes irritation, with redness and pain. Soluble fluoride may be corrosive. Effects may not appear Skin Contact: immediately Inhalation of dust may cause severe irritation to the respiratory tract, causing coughing, sore throat, and Inhalation: labored breathing. Ingestion:Ingestion may lead to dizziness, abdominal cramps, vomiting, bloody diarrhea, weakness, and convulsions. Large doses of lithium salts are toxic to the central nervous system. Irritating to skin, eyes and respiratory Acute Health Affects: tract. Lithium may cause kidney damage. May be a teratogen. Prolonged exposure to hydrolysable fluorine Chronic Health Affects:compounds can cause deterioration of bone and tooth structure. Prolonged exposure to dust of tin compounds may result in benign pneumoconiosis. NTP:No IARC:No OSHA:No SECTION 4: First Aid Measures Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need Eye Exposure: assistance in keeping their eye lids open. Get immediate medical attention. Wash the affected area with water. Remove contaminated clothes if necessary. Apply calcium gluconate jelly Skin Exposure: or water soluble calcium salts as antidote. Seek medical assistance. Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty Inhalation: in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce Ingestion: vomiting only if directed by medical personnel. SECTION 5: Fire Fighting Measures Flash Point:not applicable Autoignition Temperature:none Explosion Limits:none Extinguishing Medium:None. Material is non-flammable. Special Fire Fighting Procedures:No special fire fighting procedures required. Hazardous Combustion andIf involved in a fire this material may emit corrosive fumes of hydrofluoric acid. Decomposion Products: Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards. SECTION 6: Accidental Release Measures Small spills can be mixed with powdered sodium bicarbonate, lime, or calcium carbonate and swept up. Avoid Spill and Leak Procedures:raising dust. Spillage in areas not adequately ventilated may require an evacuation of area. Emergency response teams will require self-contained breathing apparatus. SECTION 7: Handling and Storage Handling and Storage:Store in a tightly sealed non-glass container away from moisture. SECTION 8: Exposure Controls and Personal Protection Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory. Skin Protection:Wear appropriate chemical resistant gloves and protective clothing. Ventilation:The material must be handled in an efficient fume hood. If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators Respirator: requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. Ventilation:The material must be handled in an efficient fume hood. Additional Protection:No additional protection required. SECTION 9: Physical and Chemical Properties Color and Form:white pwdr. Molecular Weight:246.56 Melting Point:no data Boiling Point:no data Vapor Pressure:not applicable Specific Gravity:no data Odor:none Solubility in Water:soluble SECTION 10: Stability and Reactivity Stability:air and moisture stable Hazardous Polymerization:no hazardous polymerization Conditions to Avoid:none Incompatibility:active metals and strong mineral acids Decomposition Products:Hydrofluoric acid, metal fluorides and metal oxyfluorides SECTION 11: Toxicological Information RTECS Data:No information available in the RTECS files. Carcinogenic Effects:no data Mutagenic Effects:no data Tetratogenic Effects:no data SECTION 12: Ecological Information Ecological Information:No information available SECTION 13: Disposal Considerations Disposal:Dispose of according to local, state and federal regulations. SECTION 14: Transportation Shipping Name (CFR):Non-hazardous Hazard Class (CFR):NA Additional Hazard Class (CFR):NA Packaging Group (CFR):NA UN ID Number (CFR):NA Shipping Name (IATA):Non-hazardous Hazard Class (IATA):NA Additional Hazard Class (IATA):NA Packaging Group (IATA):NA UN ID Number (IATA):NA SECTION 15: Regulatory Information TSCA:Not listed in the TSCA inventory. SARA (Title 313):Title compound not listed. Second Ingredient:none SECTION 16 - ADDITIONAL INFORMATION N/A |
Hazard Codes | Xi: Irritant; |
---|---|
Risk Phrases | 36/37/38 |
Safety Phrases | 26-36 |
RIDADR | UN3288 |
Packaging Group | III |
Hazard Class | 6.1 |
LITHIUM HEXAFLUOROSTANNATE |
Lithiumhexafluorostannate(IV) |
MFCD00058771 |